France· FR:63288174
ELAPRASE 2 mg/ml, solution à diluer pour perfusion
A idursulfase product containing idursulfase, registered in France by TAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE), on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Idursulfase is registered in 14 of 19 countries.
Countries holding a registration under ATC A16AB09 (idursulfase), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 9 of them publish a price we can compare per daily dose
Idursulfase · ATC A16AB09
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- IDURSULFASE
- Manufacturer
- TAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- Country
- France (FR)
- ATC code
- A16AB09
- ATC class
- Idursulfase
- Defined daily dose
- 5 mg, P
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
1 priced- cip1334009302365361 flacon(s) en verre de 3 mlEUR 2.56
- cip1334009570563391 flacon(s) en verre de 3 ml ( abrogée le 02/05/2022)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Idursulfase in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsElaprase 2 mg/ml, concentraat voor oplossing voor infusie 6 mgTakeda Pharmaceuticals International AG Ireland Branch
- CzechiaELAPRASETakeda Pharmaceuticals International AG Ireland Branch, Dublin
- CanadaELAPRASETAKEDA CANADA INC
- SwitzerlandElaprase
- SpainELAPRASE 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONTakeda Pharmaceuticals International Ag Ireland Branch
- FinlandElapraseTakeda Pharmaceuticals International AG Ireland Branch
- United KingdomElaprase 6mg/3ml concentrate for solution for infusion vialsTakeda UK Ltd
- IrelandElaprase 2 mg/ml concentrate for solution for infusionTakeda Pharmaceuticals International AG Ireland Branch
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Elaprase
- Liechtenstein · Elaprase
- Norway · Elaprase
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c18dbca5-988a-4fc7-9358-076dcf820c7c GET /v1/drugs/c18dbca5-988a-4fc7-9358-076dcf820c7c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63288174",
"date_amm": "2007-01-08",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/06/365",
"substance": "IDURSULFASE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about idursulfase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.